As a methodology that's generally been underutilized in the past, the pandemic has brought telemedicine to the forefront as a way for doctors to care for their patients, without them having to come into an office or site. But how exactly is it being used in medicine and clinical research today, and will it still be widely used after the pandemic ends? In this discussion, Kathy speaks with Dr. Thomas Fiel and Everest Group's Nitish Mittal about how telemedicine is being used today, its benefits and challenges, how it impacts diversity in clinical trials, and if they think it will still be widely used post-pandemic.